Jeffrey Courtney serves as Executive at Targanta Therapeutics Corp., where they oversee executive responsibilities. Since joining the company, Jeffrey Courtney has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 25, 2009 involved transacting 106,149 shares valued at $0.
Jeffrey Courtney currently holds 106,149 shares of Targanta Therapeutics Corp. (TARG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Courtney has been a net neutral trader of TARG stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey Courtney's most recent insider trade was on Feb 25, 2009, when they sold 106,149 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 15, 2007 | TARG | $0 | Conversion | 106,149 | $N/A | Discretionary |
| Oct 15, 2007 | TARG | $0 | Conversion | 1,523,210 | $N/A | Discretionary |